Bausch + Lomb Corporation (BLCO) Stock Price

BLCOStock

$17.15+17.87%52W

Market Cap$6.13B

P/E—

PEG Ratio0.89

Div yield—

Beta0.55

BLCO Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-18.93%

Price vs S&P 500 (4W)0.72%

PEG Ratio0.89

VGM Score57.62

P/CF (Annual)21.43x

Book Value / Share (Quarterly)$17.86

P/TBV (Annual)1.91x

Revenue Growth (3Y)10.62%

Cash Flow / Share (Quarterly)$0.38

Price vs S&P 500 (YTD)-12.41%

Gross Margin (TTM)61.44%

Net Profit Margin (TTM)-3.21%

EPS (TTM)$-0.48

10-Day Avg Trading Volume0.41M

EPS Excl Extra (TTM)$-0.48

Revenue Growth (5Y)8.38%

EPS (Annual)$-1.02

ROI (Annual)-3.12%

Gross Margin (Annual)59.81%

Net Profit Margin (5Y Avg)-2.99%

Cash / Share (Quarterly)$1.03

Revenue Growth QoQ (YoY)9.08%

ROA (Last FY)-2.57%

Revenue Growth TTM (YoY)8.85%

EBITD / Share (TTM)$1.58

ROE (5Y Avg)-2.45%

Operating Margin (TTM)6.10%

Cash Flow / Share (Annual)$-0.19

P/B Ratio0.95x

P/B Ratio (Quarterly)0.93x

Net Income / Employee (Annual)$-27,700

EV / Revenue (TTM)2.03x

Net Interest Coverage (TTM)0.25x

ROA (TTM)-1.23%

EV / EBITDA (TTM)19.21x

EPS Incl Extra (Annual)$-1.02

Current Ratio (Annual)1.55x

Quick Ratio (Quarterly)0.81x

3-Month Avg Trading Volume0.45M

52-Week Price Return17.87%

EV / Free Cash Flow (Annual)34.57x

Revenue / Employee (TTM)$409,500

Tangible BV / Share (Quarterly)$8.98

P/S Ratio (Annual)1.19x

Asset Turnover (Annual)0.36x

52-Week High$18.91

Operating Margin (5Y Avg)4.57%

EPS Excl Extra (Annual)$-1.02

CapEx CAGR (5Y)6.65%

26-Week Price Return-7.00%

Quick Ratio (Annual)0.84x

13-Week Price Return10.01%

Total Debt / Equity (Annual)0.79x

Current Ratio (Quarterly)1.55x

Enterprise Value$10.81B

Revenue / Share Growth (5Y)8.14%

Asset Turnover (TTM)0.38x

Revenue / Employee (Annual)$392,400

Inventory Turnover (Annual)2.04x

Pretax Margin (Annual)-6.21%

Cash / Share (Annual)$1.08

3-Month Return Std Dev27.30%

Gross Margin (5Y Avg)60.37%

Net Income / Employee (TTM)$-13,200

EBITDA CAGR (5Y)-8.94%

EBITDA Interim CAGR (5Y)1.11%

ROE (Last FY)-5.58%

Net Interest Coverage (Annual)0.83x

EPS Basic Excl Extra (Annual)$-1.02

P/FCF (TTM)29.58x

Receivables Turnover (TTM)4.75x

EV / Free Cash Flow (TTM)78.92x

Total Debt / Equity (Quarterly)0.80x

EPS Incl Extra (TTM)$-0.48

Receivables Turnover (Annual)4.54x

ROI (TTM)-1.49%

P/S Ratio (TTM)1.14x

Pretax Margin (5Y Avg)-0.94%

Revenue / Share (Annual)$14.42

Tangible BV / Share (Annual)$8.94

Forward P/E21.74x

Price vs S&P 500 (52W)-0.69%

Year-to-Date Return0.41%

5-Day Price Return-0.98%

EPS Normalized (Annual)$-1.02

ROA (5Y Avg)-1.02%

Net Profit Margin (Annual)-7.06%

Month-to-Date Return1.42%

Cash Flow / Share (TTM)$0.46

EBITD / Share (Annual)$1.03

Operating Margin (Annual)2.10%

LT Debt / Equity (Annual)0.78x

P/CF (TTM)13.24x

ROI (5Y Avg)-1.24%

LT Debt / Equity (Quarterly)0.80x

EPS Basic Excl Extra (TTM)$-0.48

P/TBV (Quarterly)1.84x

P/B Ratio (Annual)0.94x

Inventory Turnover (TTM)2.00x

Pretax Margin (TTM)-1.22%

Book Value / Share (Annual)$18.20

Price vs S&P 500 (13W)8.05%

Beta0.55x

P/FCF (Annual)35.67x

Revenue / Share (TTM)$14.91

ROE (TTM)-2.67%

52-Week Low$13.77

vGradeB

gGradeC

mGradeB

vgmGradeC

BLCO Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Jul 29, 2026	$0.16	$0.16	-0.34%(-$0.00)
Q1 2026	Apr 29, 2026	$0.05	$0.08	+49.17%(+$0.03)
Q4 2025	Feb 18, 2026	$0.36	$0.32	-10.30%(-$0.04)
Q3 2025	Oct 29, 2025	$0.16	$0.18	+11.91%(+$0.02)
Q2 2025	Jul 30, 2025	$0.08	$0.07	-16.89%(-$0.01)

BLCO Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.58

3.61

3.67

Industry Peers — Ophthalmic Goods(8)

Symbol	Value Score	Growth Score	Momentum Score	Price
BLCOBausch + Lomb Corporation	B	C	B	$17.15
ALCAlcon Inc. Ordinary Shares	C	C	C	$72.01
COOThe Cooper Companies, Inc. Common Stock	C	C	C	$71.17
WRBYWarby Parker Inc.	D	B	C	$25.00
EYENational Vision Holdings, Inc. Common Stock	B	D	D	$17.38
STAAStaar Surgical Co	D	C	D	$22.11
RXSTRxSight, Inc. Common Stock	B	C	B	$7.05
LUCYInnovative Eyewear, Inc. Common Stock	B	A	D	$0.95
LUCYWInnovative Eyewear, Inc. Series A Warrants 8/16/27	—	—	F	$0.04

About Bausch + Lomb Corporation

Bausch & Lomb is one of the largest US vision care companies, operating three segments: vision care (contact lenses with ~10% market share, plus brands like Biotrue and Lumify), surgical devices for ophthalmic procedures, and ophthalmic pharmaceuticals. The company was spun off from Bausch Health in 2022 and maintains the industry's largest portfolio of eye care prescriptions, with over 100 products. This diversified portfolio across consumer, surgical, and pharmaceutical markets provides exposure to multiple customer segments within ophthalmology.